Generics in Japan [Published by Marketline] Prices from USD $298

10:28 EST 20 Jan 2020 | BioPortfolio Reports

Generics in Japan


Generics in Japan industry profile provides topline qualitative and quantitative summary information including: market size value and volume 201418, and forecast to 2023. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

For the purposes of this profile, a generic drug is defined as a copy of an ethical prescription drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, offpatent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'genericeligible' market, are not included.

The Japanese generics market had total revenues of $27.3bn in 2018, representing a compound annual growth rate CAGR of 8.1% between 2014 and 2018.

Market consumption volume increased with a CAGR of 7.8% between 2014 and 2018, to reach 74% of total pharma volume.

The Japanese generics market is a priority for the Japanese government. Due to an aging population and the rising cost of branded drugs, healthcare policies to cut expenditure on medical costs have been implemented.


Save time carrying out entrylevel research by identifying the size, growth, and leading players in the generics market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan

Leading company profiles reveal details of key generics market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts by both value and volume

Reasons to buy

What was the size of the Japan generics market by value in 2018?

What will be the size of the Japan generics market in 2023?

What factors are affecting the strength of competition in the Japan generics market?

How has the market performed over the last five years?

How large is Japan's generics market in relation to its regional counterparts?

Original Article: Generics in Japan [Published by Marketline] Prices from USD $298


More From BioPortfolio on "Generics in Japan [Published by Marketline] Prices from USD $298"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...